The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


AZN  ASTRAZENECA PLC  ORD SHS $0.25

ASTRAZENECA  Currency GBX  Premium Equity Commercial Companies
Company




 Page 2 of 8

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | Next

Time/Date Code Headline Source Impact
07:00 26-Mar-2013 AZN Filing of Annual Report on Form 20-F with SEC RNS +3.50% Up
11:38 25-Mar-2013 AZN Annual Financial Report RNS +3.88% Up
07:00 25-Mar-2013 AZN AstraZeneca settles over Crestor patent RNS +3.88% Up
07:00 21-Mar-2013 AZN AstraZeneca announces agreement with Moderna RNS +6.12% Up
07:00 21-Mar-2013 AZN AstraZeneca partners Karolinska Institute RNS +6.12% Up
07:00 21-Mar-2013 AZN AstraZeneca outlines growth strategy RNS +6.12% Up
13:00 18-Mar-2013 AZN AstraZeneca to establish strategic R&D centres RNS +2.62% Up
10:00 14-Mar-2013 AZN Block Listing Application RNS +0.44% Up
07:00 05-Mar-2013 AZN Australian court holds crestor patents invalid RNS +1.09% Up
16:00 01-Mar-2013 AZN Total Voting Rights RNS +1.54% Up
10:00 27-Feb-2013 AZN Director/PDMR Shareholding RNS +2.11% Up
10:00 27-Feb-2013 AZN Director/PDMR Shareholding RNS +2.11% Up
10:00 27-Feb-2013 AZN Director/PDMR Shareholding RNS +2.11% Up
10:00 27-Feb-2013 AZN Director/PDMR Shareholding RNS +2.11% Up
16:00 01-Feb-2013 AZN Total Voting Rights RNS -2.54% Down
07:00 31-Jan-2013 AZN Final Results RNS -2.65% Down
07:00 31-Jan-2013 AZN Final Results RNS -2.65% Down
09:00 30-Jan-2013 AZN Notice of Results RNS -2.96% Down
13:00 15-Jan-2013 AZN Announces changes to Senior Executive Team RNS +1.69% Up
16:00 02-Jan-2013 AZN Total Voting Rights RNS +2.06% Up

 Page 2 of 8

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | Next


ASTRAZENECA - News Analysis

space
space

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds